• 1
    Kovacs, E. J., Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol. Today 1991. 12: 1723.
  • 2
    Ryu, J. H., Colby, T. V. and Hartman, T. E., Idiopathic pulmonary fibrosis: current concept. Mayo Clin. Proc. 1998. 73: 10851101.
  • 3
    Coker, R. K. and Laurent, G. J., Pulmonary fibrosis: cytokines in the balance. Eur. Respir. J. 1998. 11: 12181221.
  • 4
    Adamson, I. Y. R., Young, L. and Bowden, D. H., Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am. J. Pathol. 1988. 130: 377383.
  • 5
    Mason, R. J. and Williams, M. C., Type II alveolar epithelial cells. In Crystal, R. G. and West J. B. (Eds.) The lung. Raven Press, New York 1991, pp 235246.
  • 6
    Bitterman, P. B., Pathogenesis of fibrosis in acute lung injury. Am. J. Med. 1992. 92: S3943.
  • 7
    Ward, P. A. and Hunninghake, G. W., Lung inflammation and fibrosis. Am. J. Respir. Crit. Care Med. 1998. 157: S123129.
  • 8
    Bardales, R. H., Xie, S., Schaefer, R. F. and Hsu, S., Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am. J. Pathol. 1996. 149: 845852.
  • 9
    Guinee, D. G. Jr., Fleming, M., Hayashi, T., Woodward, M., Zhang, J., Walls, J., Koss, M., Ferrans, V. and Travis, W., Association of p53 and WAF1 expression with apoptosis in diffuse alveolar damage. Am. J. Pathol. 1996. 149: 531538.
  • 10
    Kuwano, K., Kunitake, R., Kawasaki, M., Nomoto, Y., Hagimoto, N., Nakanishi, Y. and Hara, N., p21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 1996. 154: 477483.
  • 11
    Kuwano, K., Hagimoto, N., Maeyama, T., Fujita, M., Yoshimi, M., Inoshima, I., Nakashima, N., Hamada, N., Watanabe, K. and Hara, N., Mitochondria-mediated apoptosis of lung epithelial cells in idiopathic interstitial pneumonias. Lab. Invest. 2002. 82: 16951706.
  • 12
    Kunitake, R., Kuwano, K., Miyazaki, H., Kawasaki, M., Hagimoto, N., Fujita, M., Kaneko, Y. and Hara, N., Expression of p53, p21 (Waf1/Cip1/Sdi1) and Fas antigen in collagen vascular and granulomatous lung disease. Eur. Respir. J. 1998. 12: 920925.
  • 13
    Trauth, B. C., Klas, C., Peters, A. M., Matzku, S., Moller, P., Falk, W., Debatin, K. M. and Krammer, P. H., Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989. 245: 301305.
  • 14
    Yonehara, S., Ishii, A. and Yonehara, M., A cell-killing monoclonal antibody (anti-fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 1989. 169: 17471756.
  • 15
    Kuwano, K., Miyazaki, H., Hagimoto, N., Kawasaki, M., Fujita, M., Kunitake, R., Kaneko, Y. and Hara, N., The involvement of Fas-Fas ligand pathway in fibrosing lung diseases. Am. J. Respir. Cell Mol. Biol. 1999. 20: 5360.
  • 16
    Hashimoto, S., Kobayashi, A., Kooguchi, K., Kitamura, Y., Onodera, H. and Nakajima, H., Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 2000. 161: 237243.
  • 17
    Kuwano, K., Hagimoto, N., Kawasaki, M., Yatomi, T., Nakamura, N., Nagata, S., Suda, T., Kunitake, R., Maeyama, T., Miyazaki, H. and Hara, N., Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J. Clin. Invest. 1999. 104: 1319.
  • 18
    Shinbori, T., Matsuki, M., Suga, M., Kakimoto, K. and Ando, M., Induction of interstitial pneumonia in autoimmune prone mice by intratracheal administration of superantigen staphylococcal enterotoxin B. Cell. Immunol. 1996. 174: 129137.
  • 19
    Liu, A. N., Mohammed, A. Z., Rice, W. R., Fiedeldey, D. T., Liebermann, J. S., Whitsett, J. A., Braciale, T. J. and Enelow, R. I., Perforin-independent CD8+ T cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-α: relative insensitivity to Fas ligand. Am. J. Respir. Cell Mol. Biol. 1999. 20: 849858.
  • 20
    Zhao, M. Q., Amir, M. K., Rice, W. R. and Enelow, R. I., Type II pneumocyte-CD8+ T cell interactions: relationship between target cell cytotoxicity and activation. Am. J. Respir. Cell Mol. Biol. 2001. 25: 362369.
  • 21
    Marrack, P. and Kappler, J., The staphylococcal enterotoxins and their relatives. Science 1990. 248: 705711.
  • 22
    White, J., Herman, A., Pullen, A. M., Kubo, R., Kappler, J. W. and Marrack, P., The Vβ-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 1989. 56: 2735.
  • 23
    Wen, L.-P., Madani, K., Fahrni, J. A., Duncan, S. R. and Rosen, G. D., Dexamethasone inhibits lung epithelial cell apoptosis induced by IFN-γ and Fas. Am. J. Physiol. 1997. 273: L921929.
  • 24
    Coulter, K. R., Doseff, A., Sweeney, P., Wang, Y., Marsh, C. B., Wewers, M. D. and Knoell, D. L., Opposing effect by cytokines on Fas-mediated apoptosis in A549 lung epithelial cells. Am. J. Respir. Cell Mol. Biol. 2002. 26: 5866.
  • 25
    Kim, K. B., Choi, Y. H., Kim, I. K., Chung, C. W., Kim, B. J., Park, Y. M. and Yung, Y. K., Potentiation of Fas- and TRAIL-mediated apoptosis by IFN-γ in A549 lung epithelial cells: enhancement of caspase-8 expression through IFN-response element. Cytokine 2002. 20: 283288.
  • 26
    Redondo, M., Ruiz-Cabello, F., Concha, A., Hortas, M. L., Serrano, A., Morell, M. and Garrido, F., Differential expression of MHC class II genes in lung tumour cell lines. Eur. J. Immunogenet. 1998. 25: 385391.
  • 27
    Vermes, I., Haanen, C., Steffens-Nakken, H. and Reutelingsperger, C., A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J. Immunol. Methods. 1995. 184: 3951.
  • 28
    Krammer, P. H., CD95 (APO-1/Fas)-mediated apoptosis: live and let die. Adv. Immunol. 1999. 71: 163210.
  • 29
    Kataoka, T., Shinohara, N., Takayama, H., Takaku, K., Kondo,S., Yonehara, S. and Nagai, K., Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J. Immunol. 1996. 156: 36783686.
  • 30
    Robinson, B. W., Rose, A. H., Hayes, A. and Musk, A. W., Increased pulmonary gamma interferon production in asbestosis. Am. Rev. Respir. Dis. 1988. 138: 278283.
  • 31
    Fujiki, M., Shinbori, T., Suga, M., Miyakawa, H. and Ando, M., Role of T cells in bronchoalveolar space in the development of interstitial pneumonia induced by superantigen in autoimmune-prone mice. Am. J. Respir. Cell Mol. Biol. 1999. 21: 675683.
  • 32
    Segel, M. J., Izbicki, G., Cohen, P. Y., Or, R., Christensen, T. G., Wallach-Dayan, S. B. and Breuer, R., Role of interferon-γ in the evolution of murine bleomycinlung fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 2003. 285: L12551262.
  • 33
    Ziesche, R., Hofbauer, E., Wittmann, K., Petkov, V. and Block, L. H., A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 1999. 341: 12641269.
  • 34
    Hein, R., Behr, J., Hundgen, M., Hunzelmann, N., Meurer, M., Braun-Falco, O., Urbanski, A. and Krieg, T., Treatment of systemic sclerosis with gamma-interferon. Br. J. Dermatol. 1992. 126: 496501.
  • 35
    Honore, I., Nunes, H., Groussard, O., Kambouchner, M., Chambellan, A., Aubier, M., Valeyre, D. and Crestani, B., Acute respiratory failure after interferon-gamma therapy of end-stage pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2003. 167: 953957.
  • 36
    Shaw, E. G., Deming, R. L., Creagan, E. T., Nair, S., Su, J. Q., Levitt, R., Steen, P. D., Wiesenfeld, M. and Mailliard, J. A., Pilot study of human recombinant interferon gamma and accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage IIIA/B nonsmall cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 1995. 31: 827831.
  • 37
    van Zandwijk, N., Groen, H. J., Postmus, P. E., Burghouts, J. T., ten Velde, G. P., Ardizzoni, A., Smith, I. E., Bass, P., Sahmoud, T., Kirkpatric, A., Dalesio, O. and Giaccone, G., Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of EORTC Lung Cancer Cooperative Group. Eur. J. Cancer 1997. 33: 17591766.
  • 38
    Gern, J. E. and Busse, W. W., Relationship of viral infections to wheezing illness and asthma. Nat. Rev. Immunol. 2002. 2: 132138.
  • 39
    Eigler, A., Sinha, B., Hartman, G. and Endres, S., Taming TNF: stratagies to restrain this proinflammatory cytokine. Immunol. Today 1997. 18: 487492.
  • 40
    Ware, L. B. and Matthay, M. A., The acute respiratory distress syndrome. N. Engl. J. Med. 2000. 342: 13341349.
  • 41
    Pope, R. M., Apoptosis as a therapeutic tool in rheumatoid arthritis. Nat. Rev. Immunol. 2002. 2: 19.
  • 42
    O'Shea, J. J., Ma, A. and Lipsky, P., Cytokines and autoimmunity. Nat. Rev. Immunol. 2002. 2: 3745.
  • 43
    Ebnet, K., Kaldjian, E. P., Anderson, A. O. and Shaw, S., Orchestrated information transfer underlying leukocyte endothelial interactions. Annu. Rev. Immunol. 1996. 14: 155177.
  • 44
    Dhein, J., Daniel, P. T., Trauth, B. C., Oehm, A., Moller, P. and Krammer, P. H., Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J. Immunol. 1992. 149: 31663173.
  • 45
    Walczak, H., Degli-Esposti, M. A., Johnson, R. S., Smolak, P. J., Waugh, J. Y., Boiani, N., Timour, M. S., Gerhart, M. J., Schooley, K. A., Smith, C. A., Goodwin, R. G. and Rauch, C. T., TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J. 1997. 16: 53865397.
  • 46
    Nicoletti, I., Migliorati, G., Paggliacci, M. C., Grignani, F. and Riccardi, C., A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 1991. 139: 271279.
  • 47
    Kayagaki, N., Kawasaki, A., Ebata, T., Ohmoto, H., Ikeda, S., Inoue, S., Yoshino, K., Okumura, K. and Yagita, H., Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med. 1995. 182: 17771783.
  • 48
    Böhm, C., Hanski, M.-L., Gratchev, A., Mann, B., Moyer, M. P., Riecken, E.-O. and Hanski, C., A modification of the JAM test is necessary for a correct determination of apoptosis induced by FasL+ adherent tumor cells. J. Immunol. Methods 1998. 217: 7178.